Highlights
NASDAQ: ALKS       Alkermes Plc
Last Price Today's Change   Day's Range   Trading Volume
58.30   -0.17 (0.29%)  57.03 - 58.76  781,800

Overview

 
Avg Volume (4 weeks):948,200
4 Weeks Range:55.62 - 63.40
4 Weeks Price Volatility (%):
34.45%
52 Weeks Range:39.65 - 63.40
52 Weeks Price Volatility (%):
78.53%
Average Price Target: 72.00
Price Target Upside/Downside: +13.70

Headlines



No recent Headlines for this stock.


Business Background

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.

  Be the first to like this.
 


 

3536  3687  575  588 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 DCTH 0.222+0.062 
 RAD 4.05+0.94 
 AMD 14.08-0.09 
 AVEO 1.95+0.70 
 BAC 22.89+0.07 
 XLF 23.99+0.10 
 VRX 17.08+1.28 
 SPY 243.26+0.13 
 VXX 12.275-0.265 
 EEM 41.90+0.40 
Partners & Brokers